|
|
|
Volumn 23, Issue 16, 2009, Pages 2199-2208
|
|
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
a
ART CC)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
VIRUS RNA;
ADOLESCENT;
ADULT;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
DISEASE COURSE;
DRUG COMBINATION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
MIDDLE AGED;
MORTALITY;
PROGNOSIS;
RISK FACTOR;
TIME;
VIROLOGY;
VIRUS LOAD;
ADOLESCENT;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MIDDLE AGED;
PROGNOSIS;
RISK FACTORS;
RNA, VIRAL;
TIME FACTORS;
VIRAL LOAD;
YOUNG ADULT;
|
|
EID: 79952117855
PISSN: None
EISSN: 14735571
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (39)
|
|
References (0)
|